Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2013
05/21/2013US8445685 Process to prepare pioglitazone via several novel intermediates
05/21/2013US8445684 Nicotinic acetylcholine receptor ligands and the uses thereof
05/21/2013US8445683 Porphyrin compounds comprising one or more pyridone moieties
05/21/2013US8445675 Storage stable perfusion solution for dihydropteridinones
05/21/2013US8445525 Carboxylic acid amides, the preparation thereof and their use as medicaments
05/21/2013US8445483 Anti-infective agents against intracellular pathogens
05/21/2013US8445476 Carbacephem β-lactam antibiotics
05/21/2013CA2662580C Tyrosine kinase inhibitors containing a zinc binding moiety
05/21/2013CA2560162C Inhibitors of iap
05/21/2013CA2548918C Alpha-amino acid derivatives and use thereof as medicines
05/21/2013CA2428753C Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
05/16/2013WO2013071093A1 Pyrazine compounds useful as inhibitors of atr kinase
05/16/2013WO2013071085A1 Pyrazine compounds useful as inhibitors of atr kinase
05/16/2013WO2013070910A1 Reducing transmission of sexually transmitted infections
05/16/2013WO2013069765A1 Nitrogenated heterocyclic compound
05/16/2013WO2013068935A1 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
05/16/2013WO2013068875A1 2-thiopyrimidinones
05/16/2013WO2013068554A1 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013WO2013068552A1 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
05/16/2013WO2013068489A1 Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a
05/16/2013WO2013068470A1 Inhibitors of phosphodiesterase type 10a
05/16/2013WO2013068463A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an n-cyclic group as vanilloid receptor ligands
05/16/2013WO2012054721A8 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
05/16/2013US20130123507 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
05/16/2013US20130123492 Acenaphtho heterocyclic compound and application thereof
05/16/2013US20130123313 Benzofuranone compound and pharmaceutical composition containing same
05/16/2013US20130123305 Fungicide hydroximoyl-tetrazole derivatives
05/16/2013US20130123284 Heterocyclic compounds useful for kinase inhibition
05/16/2013US20130123252 2,3,5-Trisubstituted Thiophene Compounds and Uses Thereof
05/16/2013US20130123251 Benzoxazine derivatives and uses thereof
05/16/2013US20130123244 Hetero-Bicyclic Derivatives as HCV Inhibitors
05/16/2013US20130123242 Compounds and methods for the treatment or prevention of flavivirus infections
05/16/2013US20130123239 Compounds having trpv1 antagonistic activity and uses thereof
05/16/2013US20130123234 Aryl- or Heteroaryl-Substituted Benzene Compounds
05/16/2013US20130123232 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2013US20130123230 2-Thiopyrimidinones
05/16/2013CA2853024A1 2-thiopyrimidinones
05/16/2013CA2852820A1 Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a
05/16/2013CA2852604A1 Inhibitors of phosphodiesterase type 10a
05/16/2013CA2849872A1 New cyclohexylamine derivatives having .beta.2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013CA2849868A1 New cyclohexylamine derivatives having .beta.2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013CA2846568A1 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
05/15/2013EP2592078A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
05/15/2013EP2592077A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
05/15/2013EP2592073A2 Human protein tyrosine phosphatase inhibitors and their use
05/15/2013EP2592072A2 Human protein tyrosine phosphatase inhibitors and their use
05/15/2013EP2592070A2 Tetrazole-substituted arylamides
05/15/2013EP2591674A1 Heterocyclic compounds as pest controllers
05/15/2013EP2591673A1 Pest control agent
05/15/2013EP2591092A1 Compounds and methods for regulating integrin cd11b/cd18
05/15/2013EP2590972A2 Chemical compounds
05/15/2013EP2590971A2 Compounds useful as antiviral agents, compositions, and methods of use
05/15/2013EP2590968A1 Cyclic ether compounds useful as kinase inhibitors
05/15/2013EP2590957A2 Chemical compounds
05/15/2013EP2590951A1 Benzenesulfonamides useful as sodium channel inhibitors
05/15/2013EP2590950A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors
05/15/2013EP2590942A1 Rho kinase inhibitors
05/15/2013CN103108872A Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives
05/15/2013CN103102348A Oxadiazole compound and preparation method thereof, medicine composition and application thereof
05/15/2013CN103102329A Synthetic method of 2,3-dihydro-[1,4]-benzothiazine compound
05/15/2013CN103102322A Oxazole compound and preparation method thereof, medicine composition and application thereof
05/15/2013CN103102314A Benzothiazole, benzimidazole, benzoxazole derivatives and preparation method and application thereof
05/15/2013CN103102303A Benzylamine derivatives as CETP inhibitors
05/15/2013CN102076671B Triazole derivative or salt thereof
05/15/2013CN101808994B Compounds and methods for kinase modulation, and indications therefor
05/15/2013CN101657446B Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
05/15/2013CN101627034B Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
05/14/2013US8440657 Substituted piperidines
05/14/2013US8440639 Combination compositions for reducing intraocular pressure
05/14/2013CA2725649C Tetomilast polymorphs
05/14/2013CA2716369C Phenoxypropylamine compounds
05/14/2013CA2637024C Substituted imidazole derivatives, compositions, and methods of use as ptpase inhibitors
05/14/2013CA2393084C Immunoassay for neonicotinyl insecticides
05/10/2013WO2013066869A1 Piperidinyl-substituted lactams as gpr119 modulators
05/10/2013WO2013066684A1 Aminopyrimidine kinase inhibitors
05/10/2013WO2013065063A1 Anhydrous form of dasatinib, process for its preparation and its use
05/10/2013WO2013064984A1 Biaryl ether sulfonamides and their use as therapeutic agents
05/10/2013WO2013064983A1 Benzenesulfonamide compounds and their use as therapeutic agents
05/10/2013WO2013064518A1 Pesticidal compounds
05/10/2013WO2013064461A2 Compounds with nematicidal activity
05/10/2013WO2013064231A1 SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
05/10/2013WO2012178015A3 Lrrk2 inhibitors
05/10/2013WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
05/10/2013CA2855019A1 Biaryl ether sulfonamides and their use as therapeutic agents
05/10/2013CA2853454A1 Aminopyrimidine kinase inhibitors
05/10/2013CA2853439A1 Benzenesulfonamide compounds and their use as therapeutic agents
05/09/2013US20130116430 Novel nicotinamide derivative or salt thereof
05/09/2013US20130116287 Fungicide hydroximoyl-heterocycles derivatives
05/09/2013US20130116247 IRE-1alpha INHIBITORS
05/09/2013US20130116241 Novel inhibitor compounds of phosphodiesterase type 10a
05/09/2013US20130116240 Indole compounds and pharmaceutical use thereof
05/09/2013US20130116233 Novel inhibitor compounds of phosphodiesterase type 10a
05/09/2013US20130116230 3-aminopyrrolidine derivatives as modulators of chemokine receptors
05/09/2013US20130116229 Novel inhibitor compounds of phosphodiesterase type 10a
05/09/2013US20130116228 Thiazoles and pyrazoles useful as kinase inhibitors
05/09/2013US20130115310 Compounds Useful as Inhibitors of ATR Kinase
05/09/2013US20130115194 Hepatitis c virus inhibitors
05/08/2013EP2589600A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
05/08/2013EP2588477A1 Quinolines as pi3k inhibitors
05/08/2013EP2588475A1 Apoptosis signal-regulating kinase inhibitors
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 628